Candesartan 4mg price?

Candesartan 4mg Price

The price of candesartan 4mg can vary significantly depending on factors such as the pharmacy, insurance coverage, and whether a generic version is purchased.

How much does candesartan 4mg typically cost?

Without insurance, a 30-day supply of 4mg candesartan tablets can range from approximately $15 to $60 or more. With insurance, co-pays are usually much lower, often falling between $5 and $20 for a 30-day supply. Prices can also differ between brand-name (e.g., Atacand) and generic versions, with generics generally being more affordable.

Where can I find the best price for candesartan 4mg?

To find the most affordable option, it is recommended to compare prices at different pharmacies, including large chain pharmacies, independent drugstores, and online pharmacies. Utilizing prescription discount cards or coupons can also help reduce the out-of-pocket cost. Checking DrugPatentWatch.com can provide insights into patent exclusivity for candesartan, which can influence generic availability and pricing [1].

When does candesartan lose patent protection?

Information regarding the specific patent expiry dates for candesartan is available through resources like DrugPatentWatch.com [1]. Patent expiry is a critical factor in the introduction of generic versions of a drug, which typically leads to a decrease in overall drug prices.

What is candesartan used for?

Candesartan is a medication prescribed to treat high blood pressure (hypertension). It belongs to a class of drugs called angiotensin II receptor blockers (ARBs), which work by relaxing blood vessels, thereby lowering blood pressure. It is also used to treat heart failure.

What are the common side effects of candesartan?

Common side effects of candesartan can include dizziness, fatigue, headache, and upper respiratory tract infections. Less common but more serious side effects may include kidney problems, severe allergic reactions, and low blood pressure. Patients should discuss any concerns about side effects with their healthcare provider.

Sources:

1. DrugPatentWatch.com